Skip to main content Back to Top


Pulmozyme Ampuls Recalled Because of Defect

Cheryl A. Thompson

Genentech Inc. is recalling Pulmozyme oral inhalation solution lot N9700A because some of the ampules have a tiny puncture and could leak.

The company said the ampules were damaged during manufacture. A similar problem occurred 13 months ago.

Pulmozyme, or dornase alfa, is used in the treatment of cystic fibrosis. The drug solution does not contain a preservative.